Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amélie Marguier
Observed names:
A. Marguier,
Amelie Marguier,
Amélie Marguier
Institution:
Genoway (France)
Observed institutions:
Inserm,
Université de Bourgogne,
Genoway (France),
Université Bourgogne Franche-Comté,
Université Marie et Louis Pasteur,
Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique,
Université de Franche-Comté
show all 7
ORCID:
0000-0002-5649-6688
Observed ORCID:
0000-0002-5649-6688
OpenAlex ID:
A5065534669
Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy
2021
·
Elodie Lauret Marie Joseph
, Amos Kirilovsky
, et al.
·
Journal for ImmunoTherapy of Cancer
·
43
PDF
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
2021
·
Charlée Nardin
, Caroline Laheurte
, et al.
·
Journal of Investigative Dermatology
·
28
TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition
2022
·
Amélie Marguier
, Caroline Laheurte
, et al.
·
Frontiers in Immunology
·
21
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption
2025
·
Morgane Lopez
, Laurie Spehner
, et al.
·
Breast Cancer Research
·
15
PDF
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma
2022
·
Caroline Laheurte
, Evan Seffar
, et al.
·
Cancer Immunology Immunotherapy
·
10
Chemotherapy to potentiate the radiation-induced immune response
2023
·
Benoît Lecoester
, Mylène Wespiser
, et al.
·
International review of cytology
·
8
Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4+ Th1 Response in Metastatic Non–Small Cell Lung Cancer
2023
·
Mylène Wespiser
, Amélie Marguier
, et al.
·
Journal of Immunotherapy
·
4
Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies
2025
·
Gaëlle H. Martin
, Siham Hedir
, et al.
·
Frontiers in Immunology
·
3
PDF
Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy
2024
·
Benoît Lecoester
, Yaoyao Xie
, et al.
·
Methods in cell biology
·
2
Abstract 3371: genO-BRGSF-HIS mice: A humanized mouse model for assessment of Treg-targeting therapies
2026
·
Gaëlle H. Martin
, Florent Creusat
, et al.
·
Cancer Research
812 NK cell recruitment into A549 TME in genO-BRGSF-HIS mice
2025
·
Siham Hedir
, Florent Creusat
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
835 γδ T cells are functional and recruited into the TME in genO-BRGSF-HIS mice
2025
·
Florent Creusat
, Siham Hedir
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Abstract 3126: Tumor microenvironment composition is shaped by tumor cell line-derived xenograft subtype and tumor burden in BRGSF-HIS mice
2025
·
Florent Creusat
, Siham Hedir
, et al.
·
Cancer Research
Abstract 5244: Functional γδ T cells in humanized mice
2025
·
Florent Creusat
, Siham Hedir
, et al.
·
Cancer Research
TIE-2–Expressing Monocytic Myeloid-Derived Suppressor Cells Are Involved in Resistance to Anti–PD-1 Therapy Mediated by Angiopoietin 2 in Patients with Melanoma
2025
·
Amélie Marguier
, Jessica Mathiot
, et al.
·
Journal of Investigative Dermatology
33P Tumor-specific CD4 Th1 responses in long-term responder melanoma patients treated with immune checkpoint inhibitors
2024
·
J. Mathiot
, B. Ndao
, et al.
·
Immuno-Oncology Technology
PDF
Etude de l'axe angiopoéïtine-2 et cellules myéloïdes suppressives exprimant TIE2 dans l'échappement tumoral et la résistance aux immunothérapies anti-PD1/PD-L1
2023
·
Amélie Marguier
·
theses.fr (ABES)
ISIDLB1657 - Tie-2 expressing monocytic myeloid-derived suppressor cells represent a resistance mechanism to anti-PD-1 therapy in melanoma
2023
·
Amelie Marguier
203P Early remodeling of systemic antitumor T cell immunity in head and neck cancer patients treated by chemoradiation
2022
·
B. Lecoester
, E. Seffar
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
19
Citation count:
134
H-index:
6
I10-index:
5
Year
Topic
Type
